a Department of Oncology , Aalborg University Hospital , Aalborg , Denmark.
b Biostatistics , HEOR Consult , Copenhagen , Denmark.
Acta Oncol. 2018 Jun;57(6):728-734. doi: 10.1080/0284186X.2018.1433319. Epub 2018 Jan 31.
To our knowledge, no prior studies have addressed the possible effects of tumour height on the accuracy of preoperative magnetic resonance imaging (MRI)-based staging relative to postoperative histopathological assessments in patients with adenocarcinoma of the rectum (RC). This study aimed to investigate whether the accuracy of preoperative MRI stage in RC is influenced by tumour height.
A total of 489 consecutive RC patients scheduled for curative treatment between 2009 and 2013 were included. Of the 489 patients, 133 patients had preoperative chemoradiotherapy (CRT), and 356 patients underwent primary surgery. Low, mid and high RC were defined as a tumour <5 cm, 5-10 cm and >10 cm from the anal verge, respectively. Diagnostic MRI and, for patients with CRT, re-staging MRI features including tumour T-stage (mrT), distance between the tumour border and the distance to the mesorectal fascia (mrMRF), extramural tumour depth (mrEMD), extramural vascular invasion (mrEMVI) and nodal involvement (mrN) were correlated with the corresponding postoperative histopathological findings.
There were 115, 186 and 188 patients with low RC, mid RC and high RC, respectively. For all patients, the correlations between mrT and pT and between mrMRF and pCRM were not influenced by tumour height. None of the correlations between mrEMD, mrEMVI and mrN and the corresponding postoperative histopathological findings significantly differed for tumours of different heights. For patients with CRT, a remarkable proportion with low RC were overstaged as ymrT3 compared to ypT0-2.
The ability to preoperatively use MRI to accurately stage is not influenced by tumour height. For patients with preoperative CRT, low RC may be MRI overstaged due to post-radiation fibrosis. We found that mrEMD predicts pEMD reliably and should therefore be considered in treatment decisions. Although new MRI techniques are emerging, preoperative RC staging remains incompletely definitive in daily clinical practice.
据我们所知,尚无研究探讨直肠腺癌(RC)患者术前磁共振成像(MRI)基于肿瘤高度的分期与术后组织病理学评估之间的可能相关性。本研究旨在探究 RC 中术前 MRI 分期的准确性是否受肿瘤高度的影响。
共纳入 2009 年至 2013 年间接受根治性治疗的 489 例连续 RC 患者。其中 133 例患者接受了术前放化疗(CRT),356 例患者接受了原发手术。低位、中位和高位 RC 定义为肿瘤距肛缘<5cm、5-10cm 和>10cm。诊断性 MRI 以及 CRT 患者的再分期 MRI 特征,包括肿瘤 T 分期(mrT)、肿瘤边界与直肠系膜筋膜(mrMRF)的距离、肿瘤外侵深度(mrEMD)、肿瘤外血管侵犯(mrEMVI)和淋巴结受累(mrN),与相应的术后组织病理学发现相关。
低 RC、中 RC 和高 RC 患者分别为 115 例、186 例和 188 例。对于所有患者,mrT 与 pT 之间以及 mrMRF 与 pCRM 之间的相关性不受肿瘤高度的影响。肿瘤高度不同时,mrEMD、mrEMVI 和 mrN 与相应的术后组织病理学发现之间的相关性均无显著差异。对于接受 CRT 的患者,与 ypT0-2 相比,相当比例的低 RC 患者被过度分期为 ymrT3。
术前使用 MRI 进行准确分期的能力不受肿瘤高度的影响。对于接受术前 CRT 的患者,由于放疗后纤维化,低位 RC 可能被 MRI 过度分期。我们发现 mrEMD 可靠地预测 pEMD,因此应在治疗决策中考虑这一点。尽管新的 MRI 技术不断涌现,但在日常临床实践中,术前 RC 分期仍不完全确定。